AWM Investment Company’s Kiora Pharmaceuticals KPRX Stock Holding History

AWM Investment Company’s Portfolio KPRX Stock Details KPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-20	Closed	-$292K	–	98
2015 Q4	$292K	Hold	20	–	–	0.06%	90
2015 Q3	$304K	Buy	+20	New	+$458K	0.06%	111

Other funds holding KPRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

VIA

Vantage Investment Advisors State College, Pennsylvania $477M AUM 17.38% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AWM Investment Company's KPRX Position: Q1 2016 in Review

AWM Investment Company sold out of Kiora Pharmaceuticals (KPRX) in Q1 2016, closing a stake of 20 shares — an estimated $292K sold.

AWM Investment Company first reported a position in KPRX in Q3 2015 and held it in 2 quarters. The position peaked at $304K in Q3 2015. 4 funds tracked by Wall St. Rank hold KPRX as of Q1 2016.

AWM Investment Company reported no remaining Kiora Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
AWM Investment Company sold 20 Kiora Pharmaceuticals shares in Q1 2016, an estimated $292K.
AWM Investment Company first reported a position in Kiora Pharmaceuticals in Q3 2015 and held it in 2 quarters.
AWM Investment Company's Kiora Pharmaceuticals position peaked at $304K in Q3 2015.
4 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q1 2016.

Based on AWM Investment Company's 13F filing for Q1 2016, filed 5 May 2016.